Impressions from EASD 2019

EASD virtual meeting site. https://www.easd.org/virtualmeeting/home.html

55th EASD annual meeting of the European Association for the Study of Diabetes, Barcelona, Spain, 16−20 September 2019. Diabetologia 2019;62(Suppl):1–600. https://doi.org/10.1007/s00125-019-4946-6

Full programme – 55th EASD annual meeting. https://upload.easd.org/download/AM2019/Flipbook/mobile/index.html#p=1

Programme at a glance – 55th EASD annual meeting. https://www.easd.org/programme-2019.html

Matthews DR, Paldanius PM, Proot P, et al for the VERIFY Study Group. Glycaemic durability of an early combination therapy with metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial. Lancet 2019;394:1519–29. https://doi.org/10.1016/S0140-6736(19)32131-2

McMurray JJV, Solomon SD, Inzucchi SE, et al for the DAPA-HF Trial Committees and Investigators. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med Sept 19, 2019. https://doi.org/10.1056/NEJMoa1911303

Felton A-M, Hall MS. Diabetes – from St Vincent to Glasgow. Have we progressed in 20 years? Br J Diabetes Vasc Dis 2009;9:142–3. https://doi.org/10.1177/1474651409341318

Sanders AM. The Melbourne Declaration on diabetes. Br J Diabetes Vasc Dis 2014;14:35-7. http://dx.doi.org/10.15277/bjdvd.2014.007

The Parliamentarians for Diabetes Global Network. www.pdgn.co.uk